Clinical Trials on Relapsed Acute Erythroid Leukemia in Japan
Total 97 results
-
AstraZenecaCompletedAcute Myeloid LeukaemiaJapan
-
GlaxoSmithKlineCompletedLeukaemia, Lymphoblastic, Acute and Lymphoma, LymphoblasticJapan
-
Daiichi Sankyo Co., Ltd.CompletedAcute Myeloid LeukemiaJapan
-
Daiichi Sankyo Co., Ltd.CompletedAcute Myeloid LeukemiaJapan
-
Osaka UniversityJapan Agency for Medical Research and DevelopmentRecruitingAcute Myeloid Leukemia in RemissionJapan
-
Astellas Pharma IncCompleted
-
Genzyme, a Sanofi CompanyCompletedAcute Myelogenous LeukemiaJapan
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Mantle Cell Lymphoma | Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaJapan
-
AmgenTerminatedRelapsed/Refractory Acute Myeloid Leukemia (AML)United States, Korea, Republic of, Australia, Japan, Germany, Canada
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid LeukemiaJapan
-
Keio UniversityCompletedAcute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaJapan
-
CelgeneCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteJapan
-
Gilead SciencesTerminatedAcute Myeloid Leukemia | Hematologic MalignancyJapan
-
Boehringer IngelheimCompleted
-
Novartis PharmaceuticalsCompletedChronic Myelogenous Leukemia | Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)Japan
-
OncoVerity, Inc.Janssen Pharmaceutical K.K.; argenxCompleted
-
Japan Adult Leukemia Study GroupUnknownLymphoblastic Leukemia, AcuteJapan
-
Japan Adult Leukemia Study GroupUnknownLymphoblastic Leukemia, AcuteJapan
-
Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid Leukemia | Multiple Myeloma | Non-Hodgkin Lymphoma | Chronic Myeloid Leukemia | Acute Lymphoid LeukemiaJapan
-
PfizerActive, not recruiting
-
Sumitomo Pharma Co., Ltd.CompletedAcute Myeloid LeukemiaJapan
-
Novartis PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Chronic Myelogenous LeukemiaJapan
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML)Japan
-
Japan Adult Leukemia Study GroupCompletedAcute Lymphoblastic LeukemiaJapan
-
Otsuka Pharmaceutical Co., Ltd.Korea Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid LeukemiaTaiwan, Korea, Republic of, Japan
-
AbbVieCompleted
-
Daiichi Sankyo Co., Ltd.Daiichi Sankyo, Inc.Completed
-
AmgenAmgen Astellas Biopharma K.K.CompletedRelapsed Refractory B Precursor Acute Lymphoblastic LeukemiaJapan
-
PfizerCompletedAcute Myeloid LeukemiaJapan
-
Institut de Recherches Internationales ServierKyowa Kirin Co., Ltd.; ADIR, a Servier Group companyCompletedAcute Lymphoblastic LeukemiaJapan
-
AmgenActive, not recruitingRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid LeukemiaUnited States, Australia, Japan, Germany, Canada
-
Astellas Pharma IncActive, not recruitingAcute Myeloid Leukemia | FLT3-mutated Acute Myeloid LeukemiaJapan, Korea, Republic of, Taiwan
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedB-cell Acute Lymphoblastic LeukemiaUnited States, United Kingdom, Japan, France
-
Bristol-Myers SquibbRecruiting
-
Genzyme, a Sanofi CompanyCompletedAcute Lymphoblastic LeukemiaJapan
-
AbbVieRecruitingAcute Myeloid LeukemiaUnited States, Israel, Japan, Australia, Korea, Republic of
-
Princess Maxima Center for Pediatric OncologyUniversity of Milano Bicocca; Amgen Europe B.VRecruitingAcute Lymphoblastic Leukemia | Mixed Phenotype Acute LeukemiaNorway, Finland, Denmark, Netherlands, Hungary, Argentina, Australia, Austria, Belgium, Czechia, France, Germany, Ireland, Italy, Japan, Portugal, Saudi Arabia, Sweden
-
Sumitomo Pharma America, Inc.RecruitingLeukemia, Myeloid, Acute | Leukemia, Lymphocytic, AcuteJapan, United States
-
Novartis PharmaceuticalsRecruitingFLT3-mutated Acute Myeloid LeukemiaKorea, Republic of, Germany, Italy, Turkey, Czechia, Jordan, Slovenia, Austria, Poland, Japan, Russian Federation, United States, Greece
-
Astellas Pharma Global Development, Inc.CompletedMyelodysplastic Syndrome | Acute Myeloid Leukemia (AML)United States, Japan
-
Novartis PharmaceuticalsCompletedAcute Myeloid LeukemiaJapan, Taiwan, Hong Kong, Thailand, Korea, Republic of, Russian Federation, Vietnam
-
Bristol-Myers SquibbTerminatedLeukemiaTaiwan, United States, Brazil, Japan, Italy, Korea, Republic of, Canada, China, Israel, Romania
-
Astellas Pharma Global Development, Inc.Active, not recruitingLeukemia, Acute Myeloid (AML)Japan, United States, Belgium, Canada, France, Germany, Israel, Italy, Korea, Republic of, Poland, Spain, Taiwan, Turkey, United Kingdom
-
AstraZenecaCompletedAcute Myeloid LeukemiaUnited States, Italy, United Kingdom, Romania, Japan, Australia, Germany, Spain, France
-
Novartis PharmaceuticalsCompletedAML and High Risk MDSGermany, Italy, France, Netherlands, United States, Australia, Japan
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid LeukemiaItaly, Spain, Canada, Germany, Korea, Republic of, Japan, Australia, France, United States, Taiwan
-
AbbVieRoche-GenentechActive, not recruitingAcute Myeloid Leukemia (AML)United States, Australia, Canada, China, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Puerto Rico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
AbbVieActive, not recruitingAcute Myeloid Leukemia (AML)United States, Argentina, Australia, Belgium, Brazil, Canada, China, Czechia, France, Germany, Greece, Hungary, Ireland, Japan, Korea, Republic of, Mexico, New Zealand, Norway, Puerto Rico, Russian Federation, South Africa, Spain, T... and more